Gene Therapy in Treating Patients With Ovarian Cancer

Completed · Phase 1

Conditions studied: Ovarian Cancer

In brief

Phase I trial to study the effectiveness of gene therapy in treating patients with ovarian cancer that has not responded to previous treatment. Inserting the p53 gene into a person's cancer cells may improve the body's ability to fight cancer or make the cancer cells more sensitive to treatment.

Key facts

Study ID

NCT00003588

Run by

National Cancer Institute (NCI)

People needed

30

Starts

1998-09-01

Last updated by the study team

2013-02-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.